C3718-301:A Phase 3 Randomized Double-blind Placebo-controlled Parallel-group Multicenter Trial of Oral IW-3718 Administered to Patients with Gastroesophageal Reflux Disease while receiving Proton Pump Inhibitors @ Long Island Clinical Research Associates

Brief description of study

The objective of this study is to evaluate the safety and efficacy of IW-3718 administered to patients with GERD who continue to have persistent symptoms, such as heartburn and regurgitation, while receiving once-daily (QD), standard dose PPIs.


Clinical Study Identifier: s17-00469
ClinicalTrials.gov Identifier: NCT03561090
Principal Investigator: Robert E Tepper.


Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.